Who Owns ALZN?

Alzamend Neuro, Inc. — Institutional Ownership & 13F Holdings

$1.08

+0.03 (+2.36%)

Market Cap

$6.8M

Shares Outstanding

3,139,860

Institutional Holders

11

Total Inst. Value

$59K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GEODE CAPITAL MANAGEMENT, LLC$36K39,152
2TRUIST FINANCIAL CORP$15K15,498
3BARCLAYS PLC$4K4,375
4BlackRock, Inc.$4K3,973
5Activest Wealth Management$1920
6SBI Securities Co., Ltd.$1718
7City State Bank$44
8Parallel Advisors, LLC$33
9BANK OF AMERICA CORP /DE/$0146
10MORGAN STANLEY$03

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold ALZN?

As of Q1 2025, 11 institutional investors report holding ALZN (Alzamend Neuro, Inc.) in their 13F filings.

Which hedge fund owns the most ALZN?

The largest institutional holder of ALZN is GEODE CAPITAL MANAGEMENT, LLC with $36K in shares.

Are institutions buying or selling ALZN?

This quarter, 3 institutions opened new positions in ALZN and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.